Last Price
13.83
Today's Change
+0.74 (5.65%)
Day's Change
13.15 - 13.96
Trading Volume
223,929
Market Cap
354 Million
Shares Outstanding
25 Million
Avg Volume
251,140
Avg Price (50 Days)
19.24
Avg Price (200 Days)
19.05
PE Ratio
-5.55
EPS
-2.49
Earnings Announcement
17-Mar-2025
Previous Close
13.09
Open
13.15
Day's Range
13.15 - 13.965
Year Range
12.12 - 48.31
Trading Volume
229,164
1 Day Change
5.65%
5 Day Change
-3.35%
1 Month Change
-24.18%
3 Month Change
-45.47%
6 Month Change
1.17%
Ytd Change
-32.99%
1 Year Change
-64.90%
3 Year Change
-84.97%
5 Year Change
-91.49%
10 Year Change
-91.49%
Max Change
-91.49%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED). The company was incorporated in 2021 and is based in New York, New York.